Background
==========

Interest in salicylates has prompted their use for lowering blood glucose in patients with diabetes since 1876 \[[@B1]\]. Although salicylate treatment of diabetes never gained wide application, the molecular mechanism of the hypoglycemic activity of aspirin has acquired renewed interest because it inhibits IκB kinase-β (IKK-β) \[[@B2]\]. From these results, Schulman hypothesized that salicylates might prevent lipid-induced activation of the serine kinase cascade involving IKK-β \[[@B3]\]: serine phosphorylation of insulin receptor substrate (IRS)-1 by activated IKK-β will decrease the ability of IRS-1 to activate phosphatidylinositol 3-kinase (PI3K), an important mediator of insulin signaling and action, thus leading to insulin resistance. By reversing IKK-β kinase activation, salicylates might enhance insulin sensitivity. Results supporting this proposal include the prevention of lipid-induced insulin resistance by salicylates in IKK-β heterozygous mice and in IKK-β knockout mice without salicylate treatment \[[@B3]\]. Furthermore, aspirin-treated mice bearing an heterozygous deletion in the gene for the IKK-β exhibited improved insulin sensitivity and reduced plasma glucose levels \[[@B4]\]. Activation of additional serine kinases promotes the development of insulin resistance by a similar mechanism \[e.g., \[[@B5],[@B6]\]\] and, for some of these kinases, salicylates inhibited their activation and improved the effects of insulin \[[@B7]-[@B9]\]. This paper presents evidence of an alternative pathway employed by aspirin and other NSAID to enhance insulin action, by impairing the physiological activation of a specific protein kinase. In cell-free extracts of isolated adipocytes, we have shown that aspirin, naproxen, nimesulide, and piroxicam inhibited cAMP-mediated PKA activation, decreasing PKA activity and reducing translocation of hormone-sensitive lipase from cytosol to fat droplets \[[@B10],[@B11]\].

A number of insulin effects on adipocytes are mimicked by H~2~O~2~\[[@B12]-[@B18]\], including inhibition of stimulated lipolysis \[[@B19]-[@B21]\]. Furthermore, it has been shown that insulin activates NADPH oxidase, which produces superoxide that spontaneously dismutates to H~2~O~2~\[[@B14],[@B21]\], transiently increasing the concentration of cellular H~2~O~2~\[[@B17],[@B20]\], and a role of H~2~O~2~ as a second messenger has been hypothesized since 1977 -- 1980 \[[@B14],[@B16],[@B19]-[@B22]\]. A new wave of data to enlarge the same topic appeared years later, i.e., H~2~O~2~ is produced by an NADPH oxidase (NOX) isoenzyme during physiological insulin transduction in adipose cells \[[@B23]\]. A substantial advance was made by Goldstein's group, who showed that insulin causes rapid formation of H~2~O~2~ in 3T3-L1 adipocytes, a redox signal that enhances the early insulin-stimulated cascade of tyrosine phosphorylation by reversible oxidative inactivation of thiol-dependent protein-tyrosine phosphatase (PTPase) 1B \[[@B24]\] and other enzymes \[[@B25],[@B26]\], which pointed to a novel regulatory mechanism complementing the early steps in insulin amplification signaling. A more recent report on insulin signaling via H~2~O~2~ during lipolysis showed that H~2~O~2~---either generated by insulin or added---reversibly inhibited the lipolysis rates activated by epinephrine or Bt~2~cAMP \[[@B27]\]. This effect took place by means of the H~2~O~2~ mediated oxidation of two sulfhydryl groups from the PKA holoenzyme: Cys 97 from regulatory IIα or IIβ subunits, and Cys 199 from the catalytic α subunit, which formed a disulfide bond that impaired cAMP activation of the holoenzyme, thus preventing PKA-stimulated lipolysis \[[@B27]\]. This information together with the inhibition of stimulated lipolysis by NSAID \[[@B10],[@B11]\] led us to propose H~2~O~2~ as the missing molecule generated by NSAID in adipocyte plasma membranes. Thus, the aim of this paper was to get insight on the molecular bases of insulin-like actions of NSAIDs.

Methods
=======

Reagents
--------

Acetylsalicylic acid (aspirin), naproxen, nimesulide, piroxicam, Bt~2~cAMP, guanosine 5′-3-*O*-(thio)triphosphate (GTPγS), HEPES, MES, MOPS, NADPH, cAMP, insulin, collagenase type II, Bovine serum albumin fraction V (BSA), catalase, Diphenyleneiodonium chloride (DPI), Cytochrome *c* (Cyt *c*), adenosine, and trichloroacetic acid (TCA) were obtained from Sigma-Aldrich (St. Louis, MO, USA, <http://www.sigmaaldrich.com>). The protease inhibitor cocktail was obtained from MP Biomedicals (Solon, OH, USA, <http://www.mpbio.com>). The Amplex Red kit was purchased from Molecular Probes, Inc. (Eugene, OR, USA, <http://www.invitrogen.com>). H~2~O~2~ was obtained from Merck (Darmstadt, Germany, <http://www.merckgroup.com>). AgNO~3~ was purchased from Baker (México, <http://www.avantormaterials.com>), polyclonal antibodies against the PKA catalytic α subunit (sc-903) and NOX4 (sc-21860) were obtained from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA, USA, <http://www.scbt.com>), and secondary antibodies were purchased from Pierce (Rockford, IL, USA, <http://www.piercenet.com/>). All other reagents were of the highest purity available commercially.

Animals
-------

Male Wistar rats weighing 200--240 g fed *ad libitum* with a commercial diet (Purina, México) and with free access to water were used. All experiments were conducted in accordance with the Federal Regulations for Animal Care and Use (NOM-062-ZOO-1999, Ministry of Agriculture, México) and were approved by the Ethics Committee of the Facultad de Medicina, Universidad Nacional Autónoma de México (UNAM).

Adipocyte isolation and measurement of lipolysis
------------------------------------------------

To isolate adipocytes with low cAMP endogenous levels, animals were fasted for 16 h as recommended by Londos \[[@B28]\]. Animals were sacrificed by decapitation and the epididymal fat pads were immediately removed. Fat pads from two rats were used in each experiment. In brief, Krebs-Ringer buffer was enriched with 25 mM HEPES, 2.5 mM CaCl~2~, 2 mM glucose, 200 nM adenosine, and fatty acid-free BSA either at 1 or 4%, as detailed later; pH was adjusted to 7.4. One gram of minced fat pads was digested in 10 ml of collagenase (1 mg/ml) for 30 min at 37°C, with shaking at 160 cycles/min in the Krebs-Ringer-enriched buffer supplemented with 1% BSA. Cells were filtered through nylon cloth and washed three times by centrifugation (1 min each) at 220 × *g*. Wet-packed adipocytes were weighed to report glycerol release by wet weight as an index of lipolysis, which was assayed using 100 μl of packed adipocytes incubated for 30 min at 37°C in a total volume of 1 ml of Krebs-Ringer-enriched buffer supplemented with 4% BSA, in which Bt~2~cAMP, isoproterenol, catalase, insulin, NSAID, DPI, anti-NOX4 antibody, Cyt *c*, and AgNO~3,~ were dissolved to reach the final concentrations indicated in the figures. Adipocytes were maintained dispersed during incubation by shaking at 160 cycles/min. Lipolysis was stopped by transferring tubes from 37°C to an ice bath for 5 min. Tubes were immediately centrifuged at 10,000 × *g* at 4°C for 10 min. A 300-μl aliquot from the solution lying below the fat cake was utilized to measure released glycerol \[[@B29]\].

Measurement of H~2~O~2~ generation in isolated adipocytes
---------------------------------------------------------

One hundred μl of packed rat adipocytes were incubated for 10 min (unless another time is indicated) at 37°C, with shaking at 160 cycles/min in a total 1-ml volume of Krebs-Ringer-enriched buffer supplemented with 4% BSA in which insulin, NSAID, DPI, Cyt *c*, anti-NOX4 antibody, and AgNO~3~ were dissolved to reach the final concentrations indicated in the figures. H~2~O~2~ generation was stopped by the addition of 100 μl of TCA 6 M, and the tubes were immediately centrifuged at 10,000 × *g* at 4°C for 10 min to measure H~2~O~2~ with the method of Zhou et al. \[[@B30]\], utilizing the Amplex Red hydrogen peroxide assay kit (Molecular Probes; A22188) according to the manufacturer's instructions.

NADPH-dependent H~2~O~2~ generation system activity
---------------------------------------------------

The procedure described to measure NADPH oxidase system activity in adipocytes was followed \[[@B23],[@B27]\]. In brief, 100 μl of packed rat adipocytes were suspended in 900 μl of ice-cold lysis medium containing 20 mM MES pH 5.8, 2 mM MgCl~2~, 1 mM CaCl~2~, 5 mM KCl, and 100 μl of protease inhibitor cocktail. Cells were lysed after vigorous mixing for 5 min in a vortex. Lysed cells were spun at 1,000 × *g* for 20 min at 4°C, the supernatant was discarded, and the precipitate with plasma membrane was suspended in the activation buffer containing 30 mM MOPS, pH 7.5, 120 mM NaCl, 1.4 mM CaCl~2~, 5 mM MgCl~2~, and 10 mM NaHCO~3~. Centrifugation was repeated, the supernatant was discarded, and the precipitate was suspended in the activation buffer supplemented or not with MnCl~2~, guanosine 5′-3-*O*-(thio)triphosphate (GTPγS), NSAID, or insulin, as detailed in the figure legends. Adipocyte plasma membranes containing the NADPH oxidase system were incubated in activation buffer at 25°C for 25 min. Then, the samples were centrifuged under the same conditions, the supernatant was discarded, and the precipitate was suspended and washed twice in catalysis buffer containing 30 mM MES, pH 5.8, 120 mM NaCl, 4 mM MgCl~2~, 1.2 mM KH~2~PO~4~, 1 mM NaN~3~, 10 mM FAD, and supplemented when indicated with DPI, Cyt *c*, anti-NOX4 antibody, and AgNO~3~. Samples were spun again, the supernatant was discarded, and these were suspended in the same buffer without supplements; the catalytic reaction was started with 250 μM NADPH and incubated for 30 min at 37°C. The reaction was stopped by placing tubes in an ice bath for 5 min, and a 5-μl aliquot from the mix reaction was employed to measure H~2~O~2~ using the Amplex Red hydrogen peroxide assay kit.

Statistics
----------

Data points shown are means ± Standard error of the mean (SEM). All statistical analyses were performed using SigmaPlot ver. 11 software (Systat Software, Inc., San Jose, CA, USA, <http://www.sigmaplot.com/>). Statistical differences were determined employing Student's *t* tests or one-way Analysis of variance (ANOVA) followed by the Dunnett or Kruskal-Wallis test. Minimum level of significance was set at *p* \<0.05.

Results
=======

Role of H~2~O~2~ on the inhibitory action of NSAID
--------------------------------------------------

On the basis of the data available, we propose that the H~2~O~2~ generated by NSAID is the intermediary that prevents PKA-stimulated lipolysis. This putative role of H~2~O~2~ was explored by adding exogenous catalase to intact isolated adipocytes challenged with Bt~2~cAMP to activate lipolysis (i.e., glycerol release). As expected, the results showed that aspirin, naproxen, nimesulide, and piroxicam at 10^--6^ M inhibited Bt~2~cAMP-activated lipolysis (*p* \<0.05) (Figure [1](#F1){ref-type="fig"}a). In contrast, catalase significantly enhanced Bt~2~cAMP-activated lipolysis, either in the absence of the cyclic nucleotide or in its presence, at all concentrations tested (Figure [1](#F1){ref-type="fig"}b). Because lipolysis inhibition elicited by the four selected NSAID at 10^--6^ M was observed when glycerol release was activated by 10^--5^ to 10^--2^ M Bt~2~cAMP, i.e., at concentrations 10 -- 10,000-fold higher than the concentration of the aspirin-like drugs (*p* \<0.05) (Figure [1](#F1){ref-type="fig"}a), direct interaction between NSAID and Bt~2~cAMP can be discarded. Furthermore, in all cases, the addition of exogenous catalase impaired NSAID-mediated inhibition of lipolysis (Figure [1](#F1){ref-type="fig"}c).

![**Effect of catalase and selected NSAID on Bt**~**2**~**cAMP-stimulated glycerol release in isolated rat adipocytes.** Panel **a**, concentration-response curve for Bt~2~cAMP without NSAID, or plus 10^--6^ M of each of the NSAID indicated in the figure. Panel **b**, concentration-response curve for Bt~2~cAMP alone or in the presence of 1,000 units of catalase. Panel **c**, concentration-response curve for Bt~2~cAMP in the presence of 1,000 units of catalase without NSAID or plus 10^--6^ M of each of the NSAID indicated in the figure. Basal glycerol release in the absence of Bt~2~cAMP is indicated by an open circle. Each point represents the average ± Standard error (SE) of three to five independent experiments. *\*,p* \< 0.05 vs Bt~2~cAMP alone.](1471-2091-14-13-1){#F1}

NSAID increased H~2~O~2~ generation through a NOX system
--------------------------------------------------------

The next experiment was to test the ability of NSAID to generate sufficient H~2~O~2~ in isolated adipocytes, in order to amplify and substantiate the inhibitory action of aspirin-like drugs on stimulated lipolysis \[[@B11]\]. The selected NSAID employed at 10^--6^ M produced a linear but transient rise in the content of H~2~O~2~, reaching a maximum concentration at 10 min of incubation followed by its rapid disappearance (not shown), indicative of a rapid turnover in the H~2~O~2~ pool, as expected for a regulatory signal. Based on these data, the 10-min incubation period was chosen to conduct further experiments. Isolated adipocytes generated H~2~O~2~ with a similar concentration-response pattern and with a peak at 10^--6^ M for each NSAID (Figure [2](#F2){ref-type="fig"}a). The transient rise in H~2~O~2~ induced by NSAID is quantitatively similar to that observed with 10^--8^ M insulin (Figure [2](#F2){ref-type="fig"}a), a hormone that follows a redox signal transduction pathway, which reversibly inhibited lipolysis \[[@B27]\]. Cell membranes prepared from adipocytes were incubated in an enriched medium with NADPH to generate H~2~O~2~ by the NOX; under these experimental conditions, NSAID increased the production of H~2~O~2~ (Figure [2](#F2){ref-type="fig"}b). A concentration-response curve of these compounds in the presence of Mn^2+^ showed an increase in the endogenous synthesis of H~2~O~2~, with a peak at 10^−6^ M for NSAID, except for aspirin, for which a value of 10^−5^ M was observed; higher concentrations of NSAID failed to increase H~2~O~2~ generation further. We have no explanation for this last observation; however, bell-shaped dose response relationships have been previously reported for other NSAID effects (e.g., \[[@B31]-[@B33]\]), pointing out the diverse and complex action mechanisms of NSAIDs. On the other hand, the decrease in H~2~O~2~ production at higher concentrations of NSAIDs cannot be explained by a toxic effect of NSAIDs on the cells, since the same type of response is obtained in both, whole cells (Figure [2](#F2){ref-type="fig"}a) and isolated plasma membranes (Figure [2](#F2){ref-type="fig"}b). Thus, the data suggest that NSAIDs effect is on NADPH oxidase system. An estimated IC~50~ near 10^−7^ M was obtained for these aspirin-like drugs \[[@B11]\] (Figure [2](#F2){ref-type="fig"}). The enzymatic system responsible for H~2~O~2~ generation in adipocytes has been identified previously as a NOX4 isoform \[[@B34]\], which can be activated by Mn^2+^ or GTP prior to interaction with hormones \[[@B23]\]. Besides NOX4, no other isoforms have been detected in adipocytes \[[@B34]\]. Results in isolated membranes of rat adipocytes showed that NOX activity was low in the absence of Mn^2+^, but that it was stimulated by all four NSAID (Figure [3](#F3){ref-type="fig"}a). After NOX activation by Mn^2+^ or GTPγS (a GTP analogue), NSAID produced greater stimulation (Figure [3](#F3){ref-type="fig"}b and [3](#F3){ref-type="fig"}c). The response observed with NSAID is similar to the response pattern obtained with insulin-challenged adipocyte plasma membranes (Figure [2](#F2){ref-type="fig"}b), which utilizes H~2~O~2~ as a second messenger \[[@B23]-[@B27]\].

![**Concentration-response curve for NSAID on H**~**2**~**O**~**2**~**generation in rat adipocytes, and in plasma membranes from adipocytes.** Panel **a**, cells were incubated for 10 min at 37°C in Krebs-Ringer-enriched buffer supplemented with 4% BSA plus 10^−8^ M insulin or NSAID at the concentrations indicated in the figure. Panel **b**, freshly prepared cell membranes were incubated for 10 min at 37°C in the activation buffer enriched with 3 mM MgCl~2~ and 4% BSA plus 10^−8^ M insulin or NSAID at the concentrations indicated in the figure. Insulin-induced H~2~O~2~ generation in the absence of NSAID is indicated by an open circle. Assay of H~2~O~2~ was conducted as described in experimental procedures and the catalytic reaction was started with 250 μM NADPH. Each point represents the average ± Standard error (SE) of three to five independent experiments. *\*, p* \< 0.05 none vs NSAID or insulin.](1471-2091-14-13-2){#F2}

![**Effect of Mn**^**2+**^**and GTPγS on insulin- and NSAID-mediated H**~**2**~**O**~**2**~**generation through a NADPH oxidase (NOX) system in isolated plasma membranes from rat adipocytes.** Freshly prepared cell membranes were incubated in activation buffer supplemented with the following: none (panel **a**); 3 mM MnCl~2~ (panel **b**), or 10^−5^ M GTPγS (panel **c**). In each instance, 10^−8^ M insulin or 10^−6^ M of each of the selected NSAID were included in the incubation mixture. Assay of H~2~O~2~ was conducted as described in Experimental Procedures. Each bar represents the average ± Standard error (SE) of three independent experiments. *\*, p* \<0.05 no addition vs insulin or NSAID.](1471-2091-14-13-3){#F3}

NSAID-activated NOX4 impairs Bt~2~cAMP-stimulated lipolysis
-----------------------------------------------------------

Experiments were designed to identify the source of the pool of H~2~O~2~ impairing Bt~2~cAMP-activated lipolysis in adipocytes. Figure [4](#F4){ref-type="fig"} shows that the stimulatory action of insulin and NSAID on NOX to raise H~2~O~2~ in isolated plasma membranes was prevented by DPI, a non-specific NOX inhibitor \[[@B35]\], by the anti-NOX4 antibody, and by oxidized Cyt *c*, which traps the electron from the superoxide ion \[[@B36]\] produced by NOX, which in turn might dismutate spontaneously to form H~2~O~2~ in a non-enzymatic reaction. Based on the fact that specific aquaporins facilitate H~2~O~2~ diffusion across membranes \[[@B37]\] and that Ag^+^ ions are potent inhibitors of these transporters \[[@B38]\], AgNO~3~ was tested to prevent H~2~O~2~ transport across the plasma cell membrane. Indeed, as can be observed in Figure [4](#F4){ref-type="fig"}, AgNO~3~ did not modify H~2~O~2~ synthesis by NOX. Figure [5](#F5){ref-type="fig"} shows that inhibition of glycerol release by aspirin-like drugs disappeared with the three compounds, impairing H~2~O~2~ synthesis, as well as with AgNO~3~ (Figure [5](#F5){ref-type="fig"}), which allows H~2~O~2~ generation but interferes with its uptake by aquaporins \[[@B38]\]. In all of these experiments, Bt~2~cAMP-activating glycerol release prevailed over the antilipolytic action of NSAID (Figure [5](#F5){ref-type="fig"}).

![**Effect of DPI, Cyt*c,*anti-NOX4 antibody, and AgNO**~**3**~**on insulin- and NSAID-mediated H**~**2**~**O**~**2**~**generation through a NOX4 system in isolated plasma membranes from rat adipocytes.** Freshly prepared membranes were incubated for 10 min at 37°C in the activation buffer enriched with 4% BSA and 10^−5^ M GTPγS. Activation buffer was additionally supplemented with the following: none (control), or 5 ×10^−5^ M DPI, or 8 × 10^−5^ M Cyt *c*, or 1:6,400 dilution anti-NOX4 antibody, or 3 × 10^−5^ M AgNO~3~. In each set of experiments, 10^−8^ M insulin or 10^−6^ M of each NSAID was added to the incubation mixture. The H~2~O~2~ assay was conducted as described in Experimental Procedures. Each bar represents the average ± Standard error (SE) of three to six independent experiments. The letters (a, b, c, d, e, f) represent a significant difference among groups with different treatments by employing one-way Analysis of variance (ANOVA) at *p* \<0.01. Groups with the same letter did not show a significant difference at *p* \<0.05.](1471-2091-14-13-4){#F4}

![**Effect of DPI, Cyt*c,*anti-NOX4 antibody, and AgNO**~**3**~**on Bt**~**2**~**cAMP-stimulated glycerol release in rat adipocytes incubated in the presence of each of the selected NSAID.** Cells were incubated for 30 min at 37°C in Krebs-Ringer supplemented with 4% BSA, 10^−3^ M Bt~2~cAMP, and 10^−6^ M of each NSAID used, as indicated in the Figure. Krebs-Ringer was additionally supplemented with the following: none (control), or 5 × 10^−5^ M DPI, or 8 × 10^−5^ M Cyt *c*, or a 1:6,400 dilution of anti-NOX4 antibody, or 3 × 10^−5^ M AgNO~3~. Each bar represents the average ± Standard error (SE) of three to six independent experiments. The letters (a, b, c, d) represent a significant difference among groups with different treatments by employing one-way Analysis of variance (ANOVA) at *p* \<0.01. Groups with the same letter did not show a significant difference at *p* \<0.05.](1471-2091-14-13-5){#F5}

Aspirin inhibition of isoproterenol-activated lipolysis
-------------------------------------------------------

Since insulin inhibits adrenaline-stimulated lipolysis \[[@B27]\], the effect of aspirin (used as an NSAID prototype) on isoproterenol-stimulated lipolysis in rat adipocytes was studied. As expected, isoproterenol-mediated lipolysis was blunted by both insulin and aspirin (Figure [6](#F6){ref-type="fig"}). This agrees with previously published results showing that NSAIDs inhibit adrenaline-stimulated lipolysis in isolated adipocytes \[[@B10]\]. Because NSAIDs did not modify the binding of adrenergic agonist to their receptor \[[@B10]\], and inhibited Bt~2~cAMP-activated lipolysis (Figure [1](#F1){ref-type="fig"}a), it is clear that the antagonistic effect of NSAIDs on isoproterenol-stimulated lipolysis is located downstream the cAMP production.

![**Effect of insulin and aspirin on isoproterenol-stimulated glycerol release in rat adipocytes.** Cells were incubated for 30 min at 37°C in Krebs-Ringer supplemented with 4% BSA and with the reagents indicated in the Figure. Each bar represents the average ± Standard error (SE) of three to six independent experiments. The letters (a, b, c) represent a significant difference among groups with different treatments by employing one-way Analysis of variance (ANOVA) at *p* \<0.01. Groups with the same letter did not show a significant difference at *p* \<0.05.](1471-2091-14-13-6){#F6}

Discussion
==========

NSAID are the most widely used drugs \[[@B39]-[@B41]\]. Their canonical molecular action inhibiting cyclooxygenases (COX) has been enlarged by numerous COX-independent actions; among these, we reported an inhibition of cAMP-mediated PKA activation in adipocytes \[[@B10],[@B11]\]. Results in this paper supply details on the molecular mechanism of this inhibition, which was obtained with NSAID concentrations within the micromolar range, near or even below the reported levels found in human blood after administration of these compounds for therapeutic purposes \[[@B42]-[@B45]\]. However, the goal of this paper was not to study NSAID antidiabetic actions \[[@B1]-[@B3],[@B46]\], but to gain insights into the molecular bases of insulin-like actions of NSAIDs on the metabolic regulation in adipose cells. Sufficient information hinted at H~2~O~2~ as the intermediate molecule between aspirin and the inhibition of stimulated lipolysis \[[@B10],[@B11],[@B27]\]. Results in Figure [1](#F1){ref-type="fig"} not only show that Bt~2~cAMP-stimulated lipolysis was decreased with aspirin, but that this inhibitory action was shared by naproxen, nimesulide, and piroxicam, and, therefore, this action might be considered as a common property of NSAIDs. Results also suggest a physiological role of H~2~O~2~ in the regulation of stimulated lipolysis, because H~2~O~2~ disappearance by supplementation with catalase permitted extra synthesis of glycerol at all doses of Bt2cAMP (Figure [1](#F1){ref-type="fig"}b). The proposal that H~2~O~2~ is produced by NOX after its activation with NSAID was inspired by the reported action of insulin on adipocytes \[[@B23]-[@B27]\]. Indeed, submicromolar concentrations of four selected NSAID raised the H~2~O~2~ pool, either in isolated adipocytes (Figure [2](#F2){ref-type="fig"}a) or in plasma membranes from adipocytes (Figure [2](#F2){ref-type="fig"}b). Products generated by NOX activation---O~2~•^**--**^ and H~2~O~2~---have multiple actions in signaling processes \[for a review, see Stone and Yang \[[@B47]\]\]. Currently, specific NOX inhibitors are not available \[[@B48]\]. However, our experiments strongly support that H~2~O~2~ was generated by the NSAID-activated NOX4 isoform based on the following pieces of independent direct or indirect evidence: i) NOX4 is the only NOX isoform expressed in adipocytes \[[@B34]\], ii) the enzymatic system responsible for H~2~O~2~ generation was inhibited with DPI (Figure [4](#F4){ref-type="fig"}), the classical and most frequently used NOX inhibitor \[[@B35]\]; iii) H~2~O~2~ synthesis blockade and subsequent inhibition of the antilipolytic action of NSAIDs was observed after the addition of either exogenous catalase or exogenous Cyt *c* (Figure [4](#F4){ref-type="fig"}), agents that decrease the H~2~O~2~ concentration resulting from NOX catalytic activity \[[@B36]\]; iv) Mn^2+^ and GTPγS-activated H~2~O~2~ synthesis in the membranes of rat adipocytes (Figure [3](#F3){ref-type="fig"}), as shown previously for activation of NOX in human adipocytes by Mn^2+^ and GTPγS \[[@B23]\]; v) AgNO~3~ which allows H~2~O~2~ generation (Figure [4](#F4){ref-type="fig"}), interferes with its antilipolytic action in whole adipocytes by inhibiting aquaporins (Figure [5](#F5){ref-type="fig"}), showing that the enzymatic system responsible for H~2~O~2~ generation (which is stimulated by NSAIDs) is located in the plasma membrane and releases H~2~O~2~ outside the cell, and vi) a very diluted solution of NOX4 antibody impaired H~2~O~2~ synthesis (Figure [4](#F4){ref-type="fig"}). This last inhibitory action of NOX4 antibodies over NADPH oxidase activity has been previously reported in both cell-free \[[@B49],[@B50]\] and intact cells assays \[[@B51],[@B52]\]. Thus, although none of the experiments described above by itself provides conclusive evidence of NOX4 activation by NSAIDs, to our knowledge there is no enzymatic system, besides NOX4, responsible for H~2~O~2~ generation at the plasma membranes of isolated adipocytes that could explain simultaneously all the results described above.

The association of H~2~O~2~ with the lipolysis in adipocytes can be supported by abundant experimental evidence. An elevated pool of H~2~O~2~ in adipocytes---as observed after incubation with insulin \[[@B23]-[@B25],[@B34]\], added H~2~O~2~\[[@B27]\], monoamine oxidase substrates \[[@B53]\], and NSAID (Figures [1](#F1){ref-type="fig"} and [5](#F5){ref-type="fig"})---resulted in inhibition of stimulated lipolysis. This inhibition of stimulated lipolysis disappeared when the pool of H~2~O~2~ was lowered with catalase \[[@B27]\] (Figure [1](#F1){ref-type="fig"}), DPI, anti-NOX4 antibody, or Cyt *c* (Figure [5](#F5){ref-type="fig"}). One exception merits special mention. It was shown that elevated production of H~2~O~2~ in AgNO~3~-treated rat adipocytes (Figure [4](#F4){ref-type="fig"}) was not followed by inhibition of the stimulated lipolysis (Figure [5](#F5){ref-type="fig"}). These results suggest that the production of H~2~O~2~ by NOX occurs outside the cell and that its subsequent uptake into the cell requires the participation of AQP3 \[[@B54]\]. These facts are in complete agreement with previous findings by Miller et al., who showed that the downstream intracellular effects of H~2~O~2~ can be regulated across cell membranes \[[@B54]\]. Our results with catalase (Figure [1](#F1){ref-type="fig"}) and Cyt *c* (Figure [4](#F4){ref-type="fig"}) in preventing NSAID-mediated inhibition of lipolysis (Figure [5](#F5){ref-type="fig"}) support this proposal. It is noteworthy within this context that three different aquaporins, AQP3, AQP7, and AQP9, are expressed in adipose tissue and that all of these are upregulated by insulin \[[@B55]\]. Interestingly, one of these aquaporins (AQP3) is capable of mediating H~2~O~2~ uptake \[[@B54]\].

We reported previously that H~2~O~2~ generated by insulin in adipose cells oxidizes two Cys residues in the type II PKA holoenzyme \[[@B27]\]. In fact, formation of a disulfide bond between Cys-199 in the catalytic α subunit and Cys-97 in the regulatory β subunit produces an inactive holoenzyme resistant to activation by cAMP, and the thioredoxin/thioredoxin reductase system is responsible for the disulfide bond reduction \[[@B27]\]. therefore, with the results obtained in this work it is possible to propose as hypothesis that H~2~O~2~ generated by NSAIDs impairs PKA catalytic function in the same way as occurs in insulin-treated adipocytes \[[@B27]\].

A recognized action of NSAID on phagocytic cells is the antagonizing effect on the production of reactive oxygen species (ROS) during the inflammatory process \[[@B56]-[@B58]\]. The effect described here for NSAID, i.e., NOX4 activation and higher production of H~2~O~2~, was observed in a non-phagocytic cell in which H~2~O~2~ mediates the physiological response to insulin \[[@B34]\]; the significance of this action might be enhanced in such cells because, as shown in this paper, PKA is an additional target molecule for H~2~O~2~. Opposite results have been described for the H~2~O~2~-mediated oxidation of other PKA types, i.e., whereas oxidation of type I PKA in skeletal muscle resulted in its activation \[[@B59]\] and type II PKA oxidation of rat adipocyte and bovine heart holoenzyme resulted in a lack of activation, even in the presence of activators \[[@B27]\]. Of great significance is the fact described in this paper that NSAID actions include the physiological amplification cascades utilized by hormones. Here we described two hormonal second messengers---H~2~O~2~ and cAMP---that are associated with NSAID effects.

Within a broad context, a synergistic role can be hypothesized for H~2~O~2~ by the convergence of two sets of facts: on the one hand, the H~2~O~2~ inhibitory effect on PTPase and other phosphatases as documented by the Goldstein group \[[@B24]-[@B26]\], and on the other hand, H~2~O~2~-mediated prevention of kinase activation, as shown for PKA in this paper and for kinases that might be inactivated by salicylates \[[@B2]-[@B9]\]; when taken together, all of these explain the NSAID effect that enhances insulin action in adipose tissue and the hypoglycemic effect of high doses of salicylates in the treatment of diabetes \[[@B3],[@B4],[@B46]\]. Also, this allows a reassessment of previously described antagonism between epinephrine and NSAID actions in rat hepatocytes \[[@B60],[@B61]\]. Furthermore, NOX4, AQP3, and type II PKA (PRKAR2A) possess wide tissue distribution according to microarray expression data found in the Gene Atlas project \[[@B62]\] (data not shown).

Conclusions
===========

NSAIDs activate NOX4 in adipocytes to produce H~2~O~2~, which impairs cAMP-dependent PKA-II activation, preventing isoproterenol-activated lipolysis. H~2~O~2~ production for signaling in adipocytes is a novel COX-independent effect of NSAID, which opens a wide horizon to decipher some of their multiple molecular actions.
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